| 2024年6月14日 - 2024年6月15日 |
Partners Louis Beardell, Laurie Burlingame, Andrew Haupt, and Steve Jannetta will speak at the 2024 @Philly Cell and Gene Therapy Annual Conference on the panel Intellectual Property Protection and Licensing Strategies for Cell and Gene Therapy Companies.
This panel, which will include NanoCell Therapeutics Inc. President and CEO Dr. Maurits Geerlings and Century Therapeutics Inc. Director Venkatesh Hariharan, Ph.D., will discuss how cell and gene therapy companies can protect their innovations through intellectual property strategies and leverage licensing to commercialize their therapies. The Intellectual Property Protection and Licensing Strategies for Cell and Gene Therapy Companies panel will take place from 10:05–11:35 am ET.
The 2024 @Philly Cell and Gene Therapy Annual Conference brings together innovators and business leaders to foster collaboration and advance cell and gene therapeutics in Greater Philadelphia.